Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
Business Wire•29/07/2026•17:42 ET
0
Whiz Insights
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
* Broadens capabilities in targeting pan-KRAS and other drivers of hard-to-treat cancers
Get started
Create a free account to read the full story.